DocGo (DCGO) EBITDA (2020 - 2026)

DocGo's EBITDA history runs 7 years deep, the most recent figure standing at -$14.9 million for Q1 2026.

• In Q1 2026, EBITDA fell 67.26% year-over-year to -$14.9 million; the TTM figure through Mar 2026 stood at -$187.2 million (down 69764.68% YoY), while the FY2025 annual figure was -$181.2 million, down 1018.61% from the prior year.
• EBITDA was -$14.9 million for Q1 2026 at DocGo, up from -$134.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $12.7 million in Q2 2022 to a low of -$134.1 million in Q4 2025.
• Historically, EBITDA has averaged -$7.8 million across 5 years, with a median of $3.4 million in 2022.
• The sharpest annual moves came in 2022 and 2025: EBITDA jumped 921.5% in 2022, then tumbled 2979.99% in 2025.
• A 5-year view of EBITDA shows it stood at $8.6 million in 2022, then declined by 3.94% to $8.2 million in 2023, then slumped by 152.8% to -$4.4 million in 2024, then sank by 2979.99% to -$134.1 million in 2025, then jumped by 88.89% to -$14.9 million in 2026.
• The last three EBITDA figures came in at -$14.9 million (Q1 2026), -$134.1 million (Q4 2025), and -$28.1 million (Q3 2025), per Business Quant data.